Concepedia

Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

Luca Arecco, Marco Bruzzone, R. Bas, Hyun Jin Kim, Antonio Di Meglio, Rinat Bernstein‐Molho, Florentine Hilbers, Katarzyna Pogoda, Estela Carrasco, Kevin Punie,

Annals of Oncology · 2024 · 21 citations · 25 references

DOIFull text

Open access

Abstract

In young BRCA carriers, differences in recurrence pattern and second primary breast cancer among hormone receptor-positive versus negative disease warrant consideration in counseling patients on treatment, follow-up, and risk-reducing surgery.

References

25

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Erik von Elm, Douglas G. Altman, Matthias Egger et al. · The Lancet · 2007 · 17.1K citations · Full text

, , +9

Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

Karoline Kuchenbaecker, John L. Hopper, Daniel R. Barnes et al. · JAMA · 2017 · 2.7K citations · Full text

Cancer statistics for adolescents and young adults, 2020

Kimberly D. Miller, Miranda M Fidler-Benaoudia, Theresa H.M. Keegan et al. · CA A Cancer Journal for Clinicians · 2020 · 1.2K citations · Full text

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

Marco Colleoni, Zhuoxin Sun, Karen N. Price et al. · Journal of Clinical Oncology · 2016 · 600 citations

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

Ellen Copson, Tom Maishman, William Tapper et al. · The Lancet Oncology · 2018 · 484 citations · Full text